|
|
|
Volumn 10, Issue 3, 2007, Pages 162-164
|
|
Second-generation pharmaceutical proteins - EUFEPS workshop on optimizing biotech medicines
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AFFILIN;
ANTICALIN;
ANTITHROMBIN ALPHA;
DEXTRAN;
ESTERASE INHIBITOR;
INSULIN ASPART;
MONOCLONAL ANTIBODY;
NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;
PANITUMUMAB;
PEGINTERFERON ALPHA2A;
POLYGLACTIN;
RECOMBINANT ANTIBODY;
RECOMBINANT ANTITHROMBIN III;
RECOMBINANT PROTEIN;
RECOMBINANT VASCULOTROPIN;
TRASTUZUMAB;
UNCLASSIFIED DRUG;
BIOTECHNOLOGY;
CONFERENCE PAPER;
DRUG CONTROL;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG INDUSTRY;
FINANCIAL MANAGEMENT;
IMMUNOGENICITY;
NONHUMAN;
PROTEIN ENGINEERING;
PROTEIN EXPRESSION;
PROTEIN MODIFICATION;
PROTEIN PROCESSING;
TRANSGENIC ANIMAL;
TRANSGENIC PLANT;
ANIMALS;
ANIMALS, GENETICALLY MODIFIED;
BIOTECHNOLOGY;
DRUG INDUSTRY;
HUMANS;
PHARMACEUTICAL PREPARATIONS;
PROTEINS;
TECHNOLOGY, PHARMACEUTICAL;
|
|
EID: 33947318052
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (0)
|
